Research and Generic/Biosimilar industries join forces against counterfeiting

December 10, 2014 9:52 AM

EFPIA, the European Federation of Pharmaceutical Industries and Associations, and EGA, the European Generic  medicines Association, are pleased to announce that EGA will be joining the European Stakeholders Model marking another positive step in the pharmaceutical industry’s united effort to combat counterfeiting.

Counterfeit medicines are a threat to human life and undermine trust in the medicines supply chain. Recent estimates by the World Health Organization (WHO) suggest that approximately 1% of medicines sold in the developed world are counterfeit and in some parts of Africa, Asia and Latin America, more than 30% of the medicines on sale are fakes.

The ESM was established for the implementation of the Falsified Medicines Directive (Directive 2011/62/EU), with participation from supply chain stakeholders that are committed to fighting against counterfeits: EFPIA, GIRP (the European Association of Pharmaceutical Full-line Wholesalers), EAEPC (The European Association of Euro-Pharmaceutical Companies), and PGEU (Pharmaceutical Group of the European Union). EGA’s participation will further strengthen the ESM.

The ESM offers a cost-effective technological solution using 2D barcoding to verify the authenticity of medicinal products, combating the entry of falsified medicines in the EU supply chain and ensuring patient safety across Europe. The pan-European medicines verification system that will help put an end to the resale of stolen and counterfeit drugs in the legitimate supply chain.

Adrian van den Hoven, Director General EGA, stated: “The EGA is proud to join forces with EFPIA, GIRP, EAEPC and PGEU in the ESM. This is an important step in the fight against counterfeit medicines. Now it’s time for us to work with the support of EU and national authorities to get the system up and running effectively while maintaining access to safe medicines for European patients”.

Richard Bergström, Director General EFPIA, stated: “I am pleased to welcome the European Generic  medicines Association to ESM. By joining together, we can best protect patients and their security. This is a solution that will have impact not only in Europe but also at global level – because counterfeiting is a global problem. I believe we can consider this as a milestone in progressing the work of the ESM, as well as in supporting the pharmaceutical industry’s united efforts to combat counterfeiting at large.”

Source: EGA press release

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)

Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!